FDA Issues Draft Guidance for AI-Enabled Medical Devices: Key Recommendations and Updates
The U.S. Food and Drug Administration (FDA) released a draft guidance titled "Artificial Intelligence-Enabled Device Software Functions: Lifecycle Man…
The U.S. Food and Drug Administration (FDA) released a draft guidance titled "Artificial Intelligence-Enabled Device Software Functions: Lifecycle Man…
At the recent Frontiers Health conference, Nicole Raleigh, web editor at pharmaphorum, had the opportunity to sit down with Marcus Bates, Vice Preside…
At the close of Frontiers Health 2024, we had the pleasure of speaking with Luca Quagliata, VP and Global Head of Medical and Scientific Affairs from …
Ascensia has created a virtual wellness zone to answer questions aligning to the IDF’s 2024 theme of ‘Diabetes and Well-being’ Insights from our expert panel of endocrinologists, psychologists and dietitians go live today in celebration of World Diabe...
At the Frontiers Health conference, Eloise McLennan, Deep Dive editor at pharmaphorum, interviewed Fabrizio Conicella, Vice-President Center of Open I…
American Heart Association Center for Health Technology & Innovation consortium advances development of evidence-based health tech solutions Tabia Health’s AI platform digitizes, orchestrates and automates care management for healthcare providers ...
Agreement further expands Aptar Pharma’s leading respiratory portfolio CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Pharma, a global leader in drug delivery and active material science solutions and services, today announced that it has entered into an ...
In today’s rapidly evolving healthcare landscape, pharmaceutical companies are increasingly adopting innovative models to stay competitive.Digital hea…
Multi-institutional study presented at the SITC annual meeting highlights the ability of Onc.AI’s imaging-based biomarker to improve identification of long-term survivors at first follow up (HR 0.33). SAN CARLOS, Calif. & WATERLOO, Ontario--(BUSINESS ...
A few weeks ago in Berlin, during the Frontiers Health 2024 conference, Deep Dive editor at pharmaphorum, Eloise McLennan, met with Anna-Maria Heiding…